Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

David M. Wright Files Rule 144 Notice for 410 Itron Shares

A Form 144 notice of proposed sale of securities was filed on November 2, 2026, by David M. Wright, identified as a member of the immediate family of an officer of Itron, Inc., covering 410 shares of Itron common stock with an aggregate market …

Anjali Anand | 02 November 2026

David M. Wright Family Account Plans 410-Share Itron Sale

A Form 144 notice of proposed sale was filed on November 2, 2026, disclosing that 410 shares of Itron, Inc. common stock are to be sold from the account of Alexander P. Wright, son of David M. Wright, an officer of the company.

Shwetambri Chauhan | 02 November 2026

Nancy E. Cooper Plans to Sell 216 Brunswick Shares

Brunswick Corp director Nancy E. Cooper filed a Form 144 notice of proposed sale of 216 shares of Brunswick common stock, with an approximate sale date of November 2, 2026.

Aakashdeep | 02 November 2026

William D Jenkins Jr. Plans to Sell 18,222 Palo Alto Networks Shares

Palo Alto Networks, Inc. officer William D Jenkins Jr. filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 18,222 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services.

Aakashdeep | 02 November 2026

Slusser Receives 2,547 RSUs from Nextpower at $0

Director Sarah A. Slusser of Nextpower Inc. filed a Form 4 on November 2, 2026, reporting the acquisition of 2,547 restricted stock units of common stock on November 1, 2026, at a price of $0.

Aditi Sarkar | 02 November 2026

Sarah Slusser Files Initial Ownership Statement at Nextpower

Director Sarah A. Slusser filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 2, 2026, reporting no securities beneficially owned as of the event date of November 1, 2026, at Nextpower Inc. (NASDAQ:NXT).

Manish Choudhary | 02 November 2026

Jazz Pharma CEO Cozadd Files to Sell 6,000 Shares in November

Jazz Pharmaceuticals Plc officer Bruce C. Cozadd filed a Form 144 notice on November 2, 2026, proposing to sell 6,000 shares of Jazz Pharmaceuticals common stock on NASDAQ with an aggregate market value of $1,295,040.

Nitish Kishor | 02 November 2026

FTAI Aviation Prices $1.0B of 7.125% Senior Notes Due 2034

FTAI Aviation Ltd. filed a Form 8-K on November 2, 2026, disclosing that its subsidiary FTAI Aviation Investors LLC priced a private offering of $1.0 billion aggregate principal amount of 7.125% senior notes due 2034.

Vinay Lochav | 02 November 2026

BWX Technologies Reports Q3 2026 Results With Revenues of $952.97M

BWX Technologies, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 2, 2026, disclosing condensed consolidated financial statements and related management discussion for the three and nine months ended September 30, 2026.

Nitish Kishor | 02 November 2026

Neurocrine Biosciences Q3 2026: Net Income Reaches $548.8M

Neurocrine Biosciences, Inc. filed its quarterly report on Form 10-Q with the SEC on November 2, 2026, covering the three and nine months ended September 30, 2026, and reporting net income of $548.8 million for the nine-month period.

Vinay Lochav | 02 November 2026
Support

Hi! How can we help you today?

Loading…